Liver Diseases  >>  entecavir  >>  Phase 2
Welcome,         Profile    Billing    Logout  

11 Trials

Remove FilterRemove Filter

Trial + Data / EventsStatusPhNRegionInterventionsSponsorConditionsPrimary complStudy compl
entecavir / Generic mfg.
NCT01026610: Safety and Efficacy Study of LB80380 in the Treatment-naive Patients of Chronic Hepatitis B

Completed
2b
115
RoW
LB80380 90 mg, LB80380, LB80380 150 mg, entecavir 0.5 mg, Baraclude
LG Life Sciences
Chronic Hepatitis B
11/10
05/11
NCT01037166: Study in Japan of the Safety And Antiviral Activity in Adults With Chronic Hepatitis B Current Lamivudine Therapy

Completed
2
84
Japan
Entecavir, Baraclude, BMS-200475
Bristol-Myers Squibb
Chronic Hepatitis B
02/05
02/05
NCT01020565: A Study in Japan of the Safety and Antiviral Activity With Chronic Hepatitis B Infection

Completed
2
60
Japan
Entecavir, Baraclude, BMS-200475
Bristol-Myers Squibb
Chronic Hepatitis B
02/05
02/05
NCT01022801: A Phase II Dose Response Study in Japan in Chronic Hepatitis B

Completed
2
120
Japan
Entecavir, Baraclude, BMS-200475
Bristol-Myers Squibb
Chronic Hepatitis B
03/05
03/05
NCT01037062: An Open-Label Rollover Study of Entecavir (BMS-200475) in Adults With Chronic Hepatitis B Infection

Completed
2
282
Japan
Entecavir, Baraclude, BMS-200475
Bristol-Myers Squibb
Chronic Hepatitis B
12/06
12/06
NCT01254994: The Efficacy and Safety of Entecavir Treatment of Patients With Acute on Chronic Hepatitis B Liver Failure

Completed
2
108
RoW
entecavir, Traditional comprehensive medical treatment
Sun Yat-sen University
Liver Failure
07/09
12/10
NCT01438424: Safety and Antiviral Activity of Entecavir in Participants With Chronic Hepatitis B Following Monotherapy in Other Entecavir Trials

Completed
2
1053
US, Canada, Europe, RoW
Entecavir, Baraclude, Lamivudine
Bristol-Myers Squibb
Hepatitis B Virus, HBV
12/09
04/11
NCT00298363 / 2005-004096-37: Study Comparing Tenofovir Disoproxil Fumarate (TDF), Emtricitabine (FTC)/TDF, and Entecavir (ETV) in the Treatment of Chronic HBV in Subjects With Decompensated Liver Disease.

Completed
2
112
US, Canada, Europe, RoW
Tenofovir disoproxil fumarate (tenofovir DF; TDF), Viread, Emtricitabine/tenofovir disoproxil fumarate (FTC/TDF), Truvada, Entecavir (ETV), Baraclude, TDF placebo, FTC/TDF placebo, ETV placebo
Gilead Sciences
Chronic Hepatitis B
04/11
04/11
LIRA-B, NCT01204762 / 2010-020387-38: Dose Ranging Study of Pegylated Interferon Lambda in Patients With Hepatitis B and Positive for the Hepatitis B e Antigen

Completed
2
197
US, Canada, Europe, RoW
pegIFN, pegIFNα-2a, Pegasys, PegIFN lambda, BMS-914143, Entecavir, Baraclude
Bristol-Myers Squibb
Hepatitis B Virus
12/13
12/13
NCT01217632: A Study of FG-3019 in Subjects With Liver Fibrosis Due to Chronic Hepatitis B Infection

Terminated
2
114
RoW
FG-3019, Placebo, Entecavir, Entecavir Dispersible (generic)
FibroGen
Liver Fibrosis Due to Chronic Hepatitis B Infection
06/15
06/15
NCT00423891 / 2005-005816-26: A Study of Entecavir in Pediatric Patients With Chronic Hepatitis B Virus (HBV)-Infection

Completed
1/2
64
US, Canada, Europe, RoW
Entecavir, Baraclude, BMS-200475
Bristol-Myers Squibb
Hepatitis B, Chronic
08/13
09/17

Download Options